These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13743428)

  • 1. Monoamine oxidase inhibition.
    ROSENBLUM I; FERGUSON FC
    Clin Pharmacol Ther; 1960; 1():692-3. PubMed ID: 13743428
    [No Abstract]   [Full Text] [Related]  

  • 2. Some remarks about monoamine oxidase and monoamine oxidase inhibitors.
    ZELLER EA
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():125-30. PubMed ID: 13788170
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic aspects of monoamine oxidase inhibition.
    WEBB JL
    Am J Cardiol; 1960 Dec; 6():1112-6. PubMed ID: 13783566
    [No Abstract]   [Full Text] [Related]  

  • 4. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A
    Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our experiences with monoamine oxidase inhibiting substances].
    TAUBER CG
    Psychiatr Neurol (Basel); 1960 Jul; 140():148-51. PubMed ID: 13775480
    [No Abstract]   [Full Text] [Related]  

  • 8. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. I. A clinical trial of Nialamide.
    DEWHURST WG; PARE CM
    J Ment Sci; 1961 Mar; 107():239-43. PubMed ID: 13722403
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of adrenaline after blockade of monoamine oxidase and catechol-O-methyltransferase.
    DE SCHAEPDRYVER AF; KIRSHNER N
    Science; 1961 Feb; 133(3452):586-7. PubMed ID: 13720844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoamine liberators and monoamine oxidase inhibitors].
    LEUSEN I
    Psychiatr Neurol (Basel); 1960 Jul; 140():154-64. PubMed ID: 13761295
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monoamine oxidase inhibitors].
    MACIAS CASTRO I
    Arch Hosp Univ; 1960; 12():330-3. PubMed ID: 13764845
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereospecificity of monoamine oxidase inhibitors.
    PLETSCHER A; GEY KF
    Science; 1958 Oct; 128(3329):900-1. PubMed ID: 13592273
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac activities of several monoamine oxidase inhibitors.
    LEE WC; SHIN WH; SHIDEMAN FE
    J Pharmacol Exp Ther; 1961 Aug; 133():180-5. PubMed ID: 13760280
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure and activity relationships of monoamine oxidase inhibitors.
    BIEL JH; NUHFER PA; CONWAY AC
    Ann N Y Acad Sci; 1959 Sep; 80():568-82. PubMed ID: 13800538
    [No Abstract]   [Full Text] [Related]  

  • 16. [On monoamine-oxidase inhibitors].
    KROEBER E
    Psychiatr Neurol (Basel); 1960 Jul; 140():92-6. PubMed ID: 13754442
    [No Abstract]   [Full Text] [Related]  

  • 17. A monoamine oxidase inhibitor in the treatment of organic disease.
    MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of relationship between inhibition of monoamine oxidase and potentiation of hexobarbital hypnosis.
    LAROCHE MJ; BRODIE BB
    J Pharmacol Exp Ther; 1960 Oct; 130():134-7. PubMed ID: 13759147
    [No Abstract]   [Full Text] [Related]  

  • 19. A new and safer monoamine oxidase inhibitor.
    ROBIE TR
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():31-48. PubMed ID: 13742239
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine oxidase inhibitors and procedures for their evaluation in vivo and in vitro.
    OZAKI M; WEISSBACH H; OZAKI A; WITKOP B; UDENFRIEND S
    J Med Pharm Chem; 1960 Dec; 2():591-607. PubMed ID: 13731832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.